On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary retroperitoneal lymph node dissection (RPLND) ...
Comparison of serum CYFRA 21-1 and ROMA in distinguishing ovarian cancer from benign pelvic masses. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include ...
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor ...
The long-term toxicities of chemotherapy and radiotherapy can represent a significant burden to testicular cancer survivors. Retroperitoneal lymph node dissection (RPLND) is an established treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results